Jatin Shah, MD, completed his medical training at Ohio State University College of Medicine, Columbus, OH, followed by a residency in internal medicine at the Cleveland Clinic. He then completed his fellowship in hematology/oncology at the University of Alabama at Birmingham.
Dr Shah is the Executive Vice President and Chief Medical Officer at Karyopharm. Formerly, for almost 10 years, he was an Associate Professor and Associate Program Director of the Malignant Hematology Fellowship, as well as Director of Myeloma Clinical and Translational Research in the Department of Lymphoma/Myeloma, Division of Cancer Medicine at MD Anderson Cancer Center in Houston, TX.
Dr Jatin Shah has served as principal investigator and co-investigator for various multiple myeloma studies, and has published articles and abstracts in many peer-reviewed journals.
Through his Twitter account, @JatinShahMD, Dr Shah shares recent research updates in multiple myeloma.